Charles Schwab’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30,387
Closed -$163K 3579
2025
Q1
$163K Hold
30,387
﹤0.01% 3280
2024
Q4
$226K Hold
30,387
﹤0.01% 3305
2024
Q3
$275K Hold
30,387
﹤0.01% 3303
2024
Q2
$323K Buy
+30,387
New +$324K ﹤0.01% 3346
2021
Q2
Sell
-23,999
Closed -$199K 3542
2021
Q1
$199K Hold
23,999
﹤0.01% 3323
2020
Q4
$156K Hold
23,999
﹤0.01% 3284
2020
Q3
$142K Hold
23,999
﹤0.01% 3225
2020
Q2
$169K Buy
+23,999
New +$175K ﹤0.01% 3193

Other funds holding ULBI

Charles Schwab's ULBI Position: Q2 2025 in Review

Charles Schwab sold out of Ultralife (ULBI) in Q2 2025, closing a stake of 30,387 shares — an estimated $163K sold.

Charles Schwab first reported a position in ULBI in Q2 2020 and held it in 8 quarters. The position peaked at $323K in Q2 2024. 63 funds tracked by Wall St. Rank hold ULBI as of Q2 2025.

  • Charles Schwab reported no remaining Ultralife position as of Q2 2025 after selling out during the quarter.
  • Charles Schwab sold 30,387 Ultralife shares in Q2 2025, an estimated $163K.
  • Charles Schwab first reported a position in Ultralife in Q2 2020 and held it in 8 quarters.
  • Charles Schwab's Ultralife position peaked at $323K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q2 2025.

Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.